Trending Now
US judge hacks $8-billion damages verdict against Johnson & Johnson in Risperdal case down...
US judge hacks $8-billion damages verdict against Johnson & Johnson in Risperdal case down to $6.8 million
UK, German cost-effectiveness bodies unconvinced by Bayer’s TRK inhibitor Vitrakvi
UK, German cost-effectiveness bodies unconvinced by Bayer's TRK inhibitor Vitrakvi
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy for Highly Drug-Resistant...
TB Alliance Announces Partnership with Hongqi Pharma to Commercialize New Therapy for Highly Drug-Resistant Forms of TB in China
Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for Stem Cell Therapy...
Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for Stem Cell Therapy Treating Neurological Disorders ...
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2020
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2020
